학술논문
Efficacy and safety of first-line veliparib and carboplatin–paclitaxel in patients with HER2− advanced germline BRCA+ breast cancer: Subgroup analysis of a randomised clinical trial
Document Type
Article
Author
Source
In European Journal of Cancer September 2021 154:35-45
Subject
Language
ISSN
0959-8049